ToxSci Advance Access originally published online on September 28, 2005
Toxicological Sciences 2006 89(1):75-82; doi:10.1093/toxsci/kfi344
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
The Aryl Hydrocarbon Receptor Directly Regulates Expression of the Potent Mitogen Epiregulin
Graduate Programs in Molecular Medicine and Molecular Toxicology, The Huck Institutes of the Life Sciences, Department of Veterinary Science and The Center for Molecular Toxicology and Carcinogenesis, The Pennsylvania State University, University Park, Pennsylvania 16802
Received June 27, 2005; accepted September 20, 2005
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) is known to cause a large number of adverse effects, mediated largely by its binding to the aryl-hydrocarbon receptor (AhR) and subsequent modulation of gene expression. It is thought that AhR mediates these effects through the untimely and disproportionate expression of specific genes. However, the exact mechanism, or the genes involved, through which TCDD leads to these effects is still unknown. This study reports the discovery of a novel target gene, epiregulin, which is regulated by TCDD-activated AhR. Epiregulin is a growth regulator which belongs to the epidermal growth factor (EGF) family. Using real time quantitative PCR (qPCR), it was established that TCDD upregulates epiregulin gene expression. The promoter region of epiregulin has a dioxin responsive element (DRE) 56 nucleotides upstream of the transcription start site, along with three potential Sp1 binding sites. Chromatin immunoprecipitation (ChIP) assays with an anti-AhR antibody showed promoter occupancy upon TCDD treatment. Luciferase reporter assays using a vector harboring the first 125 base pairs of the epiregulin rat promoter revealed an increase in signal on TCDD treatment, which was lost upon mutation of the DRE. Epiregulin and TCDD treatment mediated a dose-dependent increase in primary mouse keratinocyte growth. These results demonstrate that AhR directly increases epiregulin expression, which could play an important role in TCDD mediated tumor promotion observed in rodent models.
Key Words: AhR; epiregulin; transcription; growth factor; TCDD.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Li, F. Takeuchi, J.-a. Wang, Q. Fan, T. Komurasaki, E. M. Billings, G. Pacheco-Rodriguez, J. Moss, and T. N. Darling Mesenchymal-epithelial interactions involving epiregulin in tuberous sclerosis complex hamartomas PNAS, March 4, 2008; 105(9): 3539 - 3544. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Belguise, S. Guo, S. Yang, A. E. Rogers, D. C. Seldin, D. H. Sherr, and G. E. Sonenshein Green Tea Polyphenols Reverse Cooperation between c-Rel and CK2 that Induces the Aryl Hydrocarbon Receptor, Slug, and an Invasive Phenotype Cancer Res., December 15, 2007; 67(24): 11742 - 11750. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Rumelhard, K. Ramgolam, R. Hamel, F. Marano, and A. Baeza-Squiban Expression and role of EGFR ligands induced in airway cells by PM2.5 and its components Eur. Respir. J., December 1, 2007; 30(6): 1064 - 1073. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Wu, L. Zhang, M. S. Hoagland, and H. I. Swanson Lack of the Aryl Hydrocarbon Receptor Leads to Impaired Activation of AKT/Protein Kinase B and Enhanced Sensitivity to Apoptosis Induced via the Intrinsic Pathway J. Pharmacol. Exp. Ther., January 1, 2007; 320(1): 448 - 457. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. SH. Choi, M. A. Miller, and P. A. Harper In Utero Exposure to 2,3,7,8-Tetrachlorodibenzo-p-dioxin Induces Amphiregulin Gene Expression in the Developing Mouse Ureter Toxicol. Sci., November 1, 2006; 94(1): 163 - 174. [Abstract] [Full Text] [PDF]
|
|